Sarah Jane Greenlee
Nursing at Law St, San Diego, CA
License number
Colorado 185736
Issued Date
Apr 2, 2008
Renew Date
Apr 2, 2008
Expiration Date
Sep 30, 2008
Type
Registered Nurse
Address
Address
1035 Law St, San Diego, CA 92109
Professional information
Scientist At Isis Pharmaceuticals
Position:
Research Associate, Bioanalytical Dept at Isis Pharmaceuticals
Location:
Greater San Diego Area
Industry:
Pharmaceuticals
Work:
Isis Pharmaceuticals
since Dec 2010
-
Research Associate, Bioanalytical Dept
Isis Pharmaceuticals
Aug 2008 - Dec 2010
-
Scientist/Research Associate, RTS Screening Dept
Isis Pharmaceuticals
Jun 2007 - Aug 2008
-
Graduate Intern
UCLA
Sep 2004 - Jul 2006
-
Laboratory Assistant
Education:
San Diego State University, Graduate School of Public Health
Masters of Science, Public Health; Toxicology University of California, Los Angeles
Bachelor of Science, Biochemistry
Masters of Science, Public Health; Toxicology University of California, Los Angeles
Bachelor of Science, Biochemistry
Picu Rn
Location:
Greater San Diego Area
Industry:
Hospital & Health Care
R.n. At Rady Children's Hospital
Position:
R.N. at Rady Children's Hospital
Location:
Greater San Diego Area
Industry:
Hospital & Health Care
Work:
Rady Children's Hospital
-
R.N.
Selective Reduction Of Allelic Variants
US Patent:
2013004, Feb 21, 2013
Filed:
Feb 8, 2011
Appl. No.:
13/577622
Inventors:
C. Frank Bennett - Carlsbad CA, US
Michael Hayden - Vancouver, CA
Susan M. Freier - San Diego CA, US
Sarah Greenlee - San Diego CA, US
Jeffrey Carroll - Vancouver, CA
Simon Warby - Victoria, CA
Eric E. Swayze - Encinitas CA, US
Michael Hayden - Vancouver, CA
Susan M. Freier - San Diego CA, US
Sarah Greenlee - San Diego CA, US
Jeffrey Carroll - Vancouver, CA
Simon Warby - Victoria, CA
Eric E. Swayze - Encinitas CA, US
Assignee:
Isis Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
A61K 31/7088, A61P 25/28, A61K 31/7115, A61K 31/7125, C12N 5/071, A61K 31/712
US Classification:
514 44 A, 435375
Abstract:
Disclosed herein are antisense compounds and methods for selectively reducing expression of an allelic variant of a huntingtin gene containing a single nucleotide polymorphism (SNP). Such methods, compounds, and composition are useful to treat, prevent, or ameliorate Huntington's Disease (HD).
Selective Reduction Of Allelic Variants
US Patent:
2013004, Feb 21, 2013
Filed:
Feb 8, 2011
Appl. No.:
13/577616
Inventors:
C. Frank Bennett - Carlsbad CA, US
Susan M. Freier - San Diego CA, US
Sarah Greenlee - San Diego CA, US
Eric E. Swayze - Encinitas CA, US
Susan M. Freier - San Diego CA, US
Sarah Greenlee - San Diego CA, US
Eric E. Swayze - Encinitas CA, US
Assignee:
Isis Pharmaceuticals Inc. - Carlsbad CA
International Classification:
C12N 15/113, A61K 31/7088, A61P 25/28, A61P 25/00, A61P 25/16, A61P 11/00, A61P 1/16, A61P 11/06, A61P 29/00, A61P 27/12, A61P 3/10, A61P 9/10, A61P 27/02, A61P 9/12, A61P 3/04, A61P 25/24, A61P 35/00, C12N 5/07
US Classification:
514 44 A, 536 245, 435375
Abstract:
Disclosed herein are antisense compounds and methods for selectively of reducing expression of an allelic variant of a gene containing a single nucleotide polymorphism (SNP). Such methods, compounds, and composition are useful to treat, prevent, or ameliorate diseases, including neurodegenerative, such as Huntington's Disease (HD).